Developing a library of samples from organ transplant patients
Official title: Immune Monitoring and Assay Development in Organ Transplant Recipients
Run by Emory University · NCT01283295 · Data updated 2026-11-12
This study is collecting blood, tissue, and urine samples from organ transplant patients and healthy volunteers to see how their bodies respond to transplant treatments and medications.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Emory University Academic / other |
| Locations | 2 sites (Atlanta, Georgia and 1 other locations) |
| Status | Recruiting |
| Started | November 2007 |
| Main results expected | December 2027 |
| Study ends | December 2028 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT01283295 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include organ transplant recipients, candidates for transplantation, and healthy volunteers without end-stage organ disease.
✕Probably not a fit
Patients who do not meet the criteria for transplantation or have conditions that pose undue risk may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create a well-characterized library of blood, biopsy tissue, and urine samples from organ transplant recipients, as well as from healthy volunteers for comparison. The samples will be analyzed to understand how patients respond to transplant therapies and the immunosuppressive drugs used in transplantation. By studying these biological samples, researchers hope to tailor transplant therapies to individual patients, potentially reducing side effects. Participation involves donating samples, which will not affect the participants' treatment plans.
Why it matters
Potential benefit: If successful, this study could lead to more personalized transplant therapies that minimize side effects for patients.
How similar studies have gone: Other studies have shown success in using biological samples to improve transplant therapies, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Recipients of or candidates for organ transplantation or organ donors for recipients under evaluation at Emory University or CHOA * Normal volunteers to include individuals without any known end-stage organ disease who are not on any immunosuppressive medication, and individuals with conditions requiring immunosuppression (i.e. dermatological diseases) that do not require transplant therapies * Ability to understand the purposes and risks of the study and willingly give written informed consent, or in the case of minors, ability to give minor assent (children older than 5 years of age), in conjunction with written guardian consent Exclusion Criteria: * Patients who fail to meet the criteria for transplantation or post-transplant follow-up by Emory or Children's Healthcare of Atlanta physicians * Any condition that, in the opinion of the attending physician, would place the patient at undue risk by participating. Specific conditions include but are not limited to anemia prohibitive of phlebotomy, coagulopathy or technical considerations that would prevent acquisition of sufficient tissue on biopsy for clinical use, or medical urgency preventing timely administration of the consenting process.
Where it's running
-
Children's Healthcare of Atlanta
Atlanta, Georgia, United States Recruiting -
Emory University
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Aneesh K Mehta, MD — Emory University
- Study coordinator: Shine Thomas, CRC
- Email: shine.thomas@emoryhealthcare.org
- Phone: 404-712-2004
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Education and a smartphone app to help organ transplant patients manage life, meds, and symptoms
A smartphone app plus teaching materials are tested to see if they improve quality of life and adherence to immunosuppressive therapy for adults who have had a liver or kidney transplant.
-
Survey on medication information leaflets for organ transplant patients
This study is trying to find out what organ transplant patients and their caregivers think about the medication information leaflets to make them clearer and more helpful.
-
Collection of biological materials from organ transplant patients
This study is collecting samples from organ transplant patients to help researchers learn more about why transplants sometimes fail and to find better ways to detect rejection and other related issues.
-
Improving long-term survival for organ transplant patients
This study is testing ways to improve the long-term success of organ transplants by personalizing care and collecting samples from patients to better predict and prevent transplant rejection.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.